Goldman Sachs’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Sell |
235,155
-24,422
| -9% | -$144K | ﹤0.01% | 3649 |
|
|
2025
Q1 | $2.18M | Sell |
259,577
-205,227
| -44% | -$1.72M | ﹤0.01% | 3312 |
|
|
2024
Q4 | $3.46M | Sell |
464,804
-200,348
| -30% | -$1.49M | ﹤0.01% | 3129 |
|
|
2024
Q3 | $3.86M | Buy |
665,152
+416,060
| +167% | +$2.41M | ﹤0.01% | 2938 |
|
|
2024
Q2 | $1.66M | Buy |
249,092
+151,134
| +154% | +$1.01M | ﹤0.01% | 3297 |
|
|
2024
Q1 | $1.28M | Sell |
97,958
-255,564
| -72% | -$3.34M | ﹤0.01% | 3471 |
|
|
2023
Q4 | $4.51M | Buy |
353,522
+231,471
| +190% | +$2.95M | ﹤0.01% | 2674 |
|
|
2023
Q3 | $1.6M | Buy |
122,051
+5,313
| +5% | +$69.7K | ﹤0.01% | 3230 |
|
|
2023
Q2 | $2.99M | Sell |
116,738
-6,963
| -6% | -$178K | ﹤0.01% | 2934 |
|
|
2023
Q1 | $3.12M | Buy |
123,701
+97,115
| +365% | +$2.45M | ﹤0.01% | 2902 |
|
|
2022
Q4 | $611K | Sell |
26,586
-5,642
| -18% | -$130K | ﹤0.01% | 3984 |
|
|
2022
Q3 | $711K | Buy |
32,228
+18,444
| +134% | +$407K | ﹤0.01% | 4037 |
|
|
2022
Q2 | $198K | Buy |
13,784
+45
| +0.3% | +$646 | ﹤0.01% | 4905 |
|
|
2022
Q1 | $260K | Buy |
+13,739
| New | +$260K | ﹤0.01% | 4957 |
|
|
2021
Q3 | – | Sell |
-11,651
| Closed | -$364K | – | 5535 |
|
|
2021
Q2 | $364K | Buy |
+11,651
| New | +$364K | ﹤0.01% | 4599 |
|